ImageneBio Inc
NASDAQ Global MarketTotal Valuation
ImageneBio Inc carries a market capitalization of 54.70M, placing it among publicly traded companies globally. Its enterprise value stands at -67.69M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 54.70M |
| Enterprise Value | -67.69M |
Share Statistics
ImageneBio Inc currently has 11.28M shares outstanding.
| Shares Outstanding | 11.28M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | 0.47 |
| P/TBV Ratio | 0.47 |
| P/FCF Ratio | -1.34 |
| P/OCF Ratio | -1.34 |
Financial Position
ImageneBio Inc maintains a current ratio of 21.47, meaning it holds 21.5x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 21.47 |
| Quick Ratio | 20.71 |
| Debt / Equity | 1.35 |
| Debt / EBITDA | -0.03 |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | -73.88 |
| Return on Assets (ROA) | -69.04 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Taxes
| Income Tax | -324,000.00 |
| Effective Tax Rate | N/A |
Stock Price Statistics
ImageneBio Inc's stock has declined approximately -42.60355% over the past 52 weeks. The 50-day moving average sits at 5.69, while the 200-day moving average is 6.06.
| Beta (5Y) | N/A |
| 52-Week Price Change | -42.60355% |
| 50-Day Moving Average | 5.69 |
| 200-Day Moving Average | 6.06 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -57.74M, while operating income came in at -58.96M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -58.96M |
| Pretax Income | -52.81M |
| Net Income | -52.48M |
| EBITDA | -57.74M |
| EBIT | -58.96M |
| Earnings Per Share (EPS) | -4.39 |
Balance Sheet
ImageneBio Inc holds 136.15M in cash and equivalents against 1.91M in total debt, resulting in a net debt position of -94.68M. Total book value stands at 142.07M, with working capital of 134.54M providing operational flexibility.
| Cash & Cash Equivalents | 136.15M |
| Total Debt | 1.91M |
| Net Debt | -94.68M |
| Equity (Book Value) | 142.07M |
| Book Value Per Share | 12.60 |
| Working Capital | 134.54M |
Cash Flow
ImageneBio Inc produced -52.59M in operating cash flow over the past twelve months.
| Operating Cash Flow | -52.59M |
| Capital Expenditures | N/A |
| Free Cash Flow | -52.59M |
| FCF Per Share | -4.39 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -221.24 |
| FCF Yield | -74.48 |
Stock Splits
ImageneBio Inc's most recent stock split took place on July 28, 2025 with a 12:1 split ratio.
| Last Split Date | 7/28/2025 |
| Split Ratio | 12:1 |
Scores
ImageneBio Inc posts an Altman Z-Score of 1.48, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 1.48 |